Literature DB >> 25454489

The activation status of human macrophages presenting antigen determines the efficiency of Th17 responses.

Christina E Arnold1, Peter Gordon, Robert N Barker, Heather M Wilson.   

Abstract

Macrophages are antigen presenting cells that can adopt different activation states as directed by microenvironmental stimuli. It is well-recognised how CD4(+) T helper (Th) signals drive macrophage activation, but the ability of differentially activated human macrophages to stimulate the major types of CD4(+) T helper (Th) response by presenting antigen have not been well defined. Previous studies have focussed on murine cells, undifferentiated human monocytes, or macrophage products, and have been limited to non-physiological mitogenic Th responses. The aim was therefore to compare the Th cell polarising abilities of different human macrophage subsets when presenting specific antigen. We demonstrate for the first time that the way macrophages are activated, while naturally presenting antigen, has profound effects on downstream adaptive immune responses. In autologous co-cultures, LPS-activation was the most potent stimulus for antigen-loaded macrophages to drive Th17 polarisation from both unfractionated CD4(+) T-cells and the CD45RO(+) memory population, while IFNγ/LPS activated macrophages preferentially induced a Th1 phenotype. By contrast, IL-4-activated macrophages were ineffective in inducing responses by either Th subset. Although antigen-loaded dendritic cells were superior to macrophages in driving Th1 responses, the Th17 polarising capacity of the two antigen-presenting cell types was equivalent, and was strongly dependent on IL-1β secretion. Taken together, these results clearly demonstrate for the first time how differentially activated human macrophages present antigen to bias specific, rather than mitogen-driven, Th responses and lead us to propose that they impact adaptive immunity in vivo, particularly in determining Th17 polarisation within inflamed tissues.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25454489     DOI: 10.1016/j.imbio.2014.09.022

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  26 in total

Review 1.  Interactions of hyperhomocysteinemia and T cell immunity in causation of hypertension.

Authors:  Sudhakar Veeranki; Siva K Gandhapudi; Suresh C Tyagi
Journal:  Can J Physiol Pharmacol       Date:  2016-04-28       Impact factor: 2.273

Review 2.  Macrophage phenotype in response to ECM bioscaffolds.

Authors:  Luai Huleihel; Jenna L Dziki; Joseph G Bartolacci; Theresa Rausch; Michelle E Scarritt; Madeline C Cramer; Tatiana Vorobyov; Samuel T LoPresti; Ilea T Swineheart; Lisa J White; Bryan N Brown; Stephen F Badylak
Journal:  Semin Immunol       Date:  2017-07-21       Impact factor: 11.130

Review 3.  Macrophage heterogeneity and renin-angiotensin system disorders.

Authors:  Mark D Wright; Katrina J Binger
Journal:  Pflugers Arch       Date:  2017-02-08       Impact factor: 3.657

4.  Activation of Myeloid TLR4 Mediates T Lymphocyte Polarization after Traumatic Brain Injury.

Authors:  Molly Braun; Kumar Vaibhav; Nancy Saad; Sumbul Fatima; Darrell W Brann; John R Vender; Lei P Wang; Md Nasrul Hoda; Babak Baban; Krishnan M Dhandapani
Journal:  J Immunol       Date:  2017-03-24       Impact factor: 5.422

5.  Impact of Notch1 Deletion in Macrophages on Proinflammatory Cytokine Production and the Outcome of Experimental Autoimmune Encephalomyelitis.

Authors:  Wipawee Wongchana; Rebecca G Lawlor; Barbara A Osborne; Tanapat Palaga
Journal:  J Immunol       Date:  2015-10-26       Impact factor: 5.422

Review 6.  Pathogenesis and treatment of autoimmune rheumatic diseases.

Authors:  Eric Liu; Andras Perl
Journal:  Curr Opin Rheumatol       Date:  2019-05       Impact factor: 5.006

7.  Transient blocking of NK cell function with small molecule inhibitors for helper dependant adenoviral vector-mediated gene delivery.

Authors:  Manjunatha Ankathatti Munegowda; Jim Hu
Journal:  Cell Biosci       Date:  2015-06-11       Impact factor: 7.133

8.  Nivolumab Enhances In Vitro Effector Functions of PD-1+ T-Lymphocytes and Leishmania-Infected Human Myeloid Cells in a Host Cell-Dependent Manner.

Authors:  Christodoulos Filippis; Katharina Arens; Gaetan Aime Noubissi Nzeteu; Gabriele Reichmann; Zoe Waibler; Peter Crauwels; Ger van Zandbergen
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

9.  M(IL-4) Tissue Macrophages Support Efficient Interferon-Gamma Production in Antigen-Specific CD8+ T Cells with Reduced Proliferative Capacity.

Authors:  Rylend Mulder; Andra Banete; Kyle Seaver; Sameh Basta
Journal:  Front Immunol       Date:  2017-11-30       Impact factor: 7.561

10.  MK2: an unrecognized regulator of tumor promoting macrophages in colorectal cancer?

Authors:  Eliseo F Castillo; Anita L Ray; Ellen J Beswick
Journal:  Macrophage (Houst)       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.